These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Dearden C; Wade R; Else M; Richards S; Milligan D; Hamblin T; Catovsky D; ; ; Blood; 2008 Feb; 111(4):1820-6. PubMed ID: 18055869 [TBL] [Abstract][Full Text] [Related]
4. The effect of fludarabine on interferon-gamma production by lymphoid cells from healthy donors and patients with B-cell chronic lymphocytic leukemia. Gamberale R; Fernández-Calotti P; Sánchez-Avalos J; Alberto MF; Geffner J; Giordano M Haematologica; 2006 Apr; 91(4):574-6. PubMed ID: 16533725 [TBL] [Abstract][Full Text] [Related]
8. Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors. Borthakur G; O'Brien S; Wierda WG; Thomas DA; Cortes JE; Giles FJ; Kantarjian HM; Lerner S; Keating MJ Br J Haematol; 2007 Mar; 136(6):800-5. PubMed ID: 17341265 [TBL] [Abstract][Full Text] [Related]
9. [Acquired pure red cell aplasia in a patient with B cell chronic lymphocytic leukemia after fludarabine therapy]. Tsuji T; Hirano T; Yamasaki H; Tuda H Rinsho Ketsueki; 2015 Jun; 56(6):705-10. PubMed ID: 26256883 [TBL] [Abstract][Full Text] [Related]
10. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice? Smolej L Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397 [No Abstract] [Full Text] [Related]
13. Recurrence of autoimmune thrombocytopenia after treatment with fludarabine in a patient with chronic lymphocytic leukemia. Montillo M; Tedeschi A; Leoni P Leuk Lymphoma; 1994 Sep; 15(1-2):187-8. PubMed ID: 7858499 [No Abstract] [Full Text] [Related]
14. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia. Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014 [TBL] [Abstract][Full Text] [Related]
15. Fludarabine and autoimmune hemolytic anemia in chronic lymphocytic leukemia. Longo G; Gandini G; Ferrara L; Torelli U; Emilia G Eur J Haematol; 1997 Aug; 59(2):124-5. PubMed ID: 9293862 [No Abstract] [Full Text] [Related]
16. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Diehl LF; Ketchum LH Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530 [TBL] [Abstract][Full Text] [Related]
17. Evan's syndrome precipitated by fludarabine therapy in a case of CLL. Sen K; Kalaycio M Am J Hematol; 1999 Jul; 61(3):219. PubMed ID: 10398320 [No Abstract] [Full Text] [Related]
18. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091 [No Abstract] [Full Text] [Related]
19. Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience. Montserrat E; Lopez-Lorenzo JL; Manso F; Martin A; Prieto E; Arias-Sampedro J; Fernandez MN; Oyarzabal FJ; Odriozola J; Alcala A; Garcia-Conde J; Guardia R; Bosch F Leuk Lymphoma; 1996 May; 21(5-6):467-72. PubMed ID: 9172812 [TBL] [Abstract][Full Text] [Related]